SXTC
NASDAQ · Pharmaceuticals
China Sxt Pharmaceuticals In
$1.73
+0.07 (+4.22%)
Open$1.67
Previous Close$1.66
Day High$1.76
Day Low$1.67
52W High$1,046.98
52W Low—
Volume—
Avg Volume22.5K
Market Cap1.66M
P/E Ratio—
EPS$-161.77
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 175.76M | 200.89M | 998.7K |
| Net Income | -333,524,860 | -343,093,352 | 158.4K |
| Profit Margin | -189.8% | -180.3% | 15.9% |
| EBITDA | -260,505,031 | -282,866,361 | 317.7K |
| Free Cash Flow | — | — | 143.5K |
| Rev Growth | -12.5% | -12.5% | +6.7% |
| Debt/Equity | 0.05 | 0.05 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |